Polo-like kinases: structural variations lead to multiple functions | Nature Reviews Molecular Cell Biology
![PDF] Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome-dependent proteolysis. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1fab03d33f093b807e4c4dea23eab368e3b4ae0c/3-Figure1-1.png "PDF] Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome-dependent proteolysis. | Semantic Scholar")
PDF] Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome-dependent proteolysis. | Semantic Scholar
Polo-like kinases: structural variations lead to multiple functions | Nature Reviews Molecular Cell Biology
![The Polo-like kinase 1 inhibitor onvansertib represents a relevant treatment for head and neck squamous cell carcinoma resistant to cisplatin and radiotherapy [Abstract]](https://www.thno.org/v11/p9571/toc.jpg "The Polo-like kinase 1 inhibitor onvansertib represents a relevant treatment for head and neck squamous cell carcinoma resistant to cisplatin and radiotherapy [Abstract]")
The Polo-like kinase 1 inhibitor onvansertib represents a relevant treatment for head and neck squamous cell carcinoma resistant to cisplatin and radiotherapy [Abstract]
Regulation of mitotic progression by Polo-like kinase 1 (PLK1). PLK1... | Download Scientific Diagram
Molecular and structural basis of polo-like kinase 1 substrate recognition: Implications in centrosomal localization | PNAS
Functional Dynamics of Polo-Like Kinase 1 at the Centrosome | Molecular and Cellular Biology
Polo-like kinase 1 inhibition in NSCLC: mechanism of action and emergi | LCTT
Cancers | Free Full-Text | The Emerging Role of Polo-Like Kinase 1 in Epithelial-Mesenchymal Transition and Tumor Metastasis
Structural basis for the inhibition of Polo-like kinase 1 | Nature Structural & Molecular Biology
Polo-like kinase 1 (PLK1) signaling in cancer and beyond - ScienceDirect
Polo-like Kinase 1 Inhibitors in Human Cancer Therapy: Development and Therapeutic Potential | Journal of Medicinal Chemistry
Figure 2 from Polo-like kinase (PLK) inhibitors in preclinical and early clinical development in oncology. | Semantic Scholar
Peptidomimetics Targeting the Polo-box Domain of Polo-like Kinase 1 | Journal of Emerging Investigators
Polo-like kinase 1 induces epithelial-to-mesenchymal transition and promotes epithelial cell motility by activating CRAF/ERK signaling | eLife
A unified view of spatio-temporal control of mitotic entry: Polo kinase as the key | Open Biology
Functions of Polo-Like Kinases: A Journey From Yeast To Humans | Bentham Science
Role of polo-like kinase 1 (PLK1) overexpression in cancer. In addition... | Download Scientific Diagram
Polo-like Kinase 1 Licenses CENP-A Deposition at Centromeres - ScienceDirect
Switching Polo-like kinase-1 on and off in time and space: Trends in Biochemical Sciences
Frontiers | A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of Rhabdomyosarcomas
Pharmaceuticals | Free Full-Text | Inhibition of Polo-like Kinase 1 by HMN-214 Blocks Cell Cycle Progression and Inhibits Neuroblastoma Growth
Continuous polo-like kinase 1 activity regulates diffusion to maintain centrosome self-organization during mitosis | PNAS
PLK-1 Inhibitors: New Treatment for MDS? - ppt download
Polo-like kinases: conservation and divergence in their functions and regulation | Nature Reviews Molecular Cell Biology
